Serum high-sensitivity C-reactive protein as a biomarker in patients with metabolic syndrome: evidence-based study with 7284 subjects

Background/Objectives: Metabolic syndrome (MetS) is characterized by abdominal obesity, dyslipidemia, hypertension and glucose intolerance, and is associated with an increased risk of developing cardiovascular disease (CVD), diabetes mellitus and related diseases. Circulating levels of inflammatory...

Full description

Saved in:

Bibliographic Details
Published in:	European journal of clinical nutrition Vol. 70; no. 11; pp. 1298 - 1304
Main Authors:	Mirhafez, S R, Ebrahimi, M, Saberi Karimian, M, Avan, A, Tayefi, M, Heidari-Bakavoli, A, Parizadeh, M R, Moohebati, M, Azarpazhooh, M R, Esmaily, H, Nematy, M, Safarian, M, Ferns, G A, Ghayour-Mobarhan, M
Format:	Journal Article
Language:	English
Published:	London Nature Publishing Group UK 01.11.2016 Nature Publishing Group
Subjects:	631/114 706/648 82/80 Adult Aged Anthropometry Arteriosclerosis Atherosclerosis Biological markers Biomarkers Biomarkers - blood Blood pressure C-reactive protein C-Reactive Protein - metabolism Cardiovascular diseases Chemical properties Cholesterol, HDL - blood Cholesterol, LDL - blood Clinical Nutrition Density Diabetes mellitus Diagnosis Dyslipidemia Epidemiology Evidence-Based Medicine Female Glucose Glucose tolerance Health aspects Heart diseases High density lipoprotein Humans Hypertension Inflammation Internal Medicine Intolerance Male Medicine Medicine & Public Health Metabolic Diseases Metabolic disorders Metabolic syndrome Metabolic Syndrome - blood Metabolic syndrome X Metabolism Middle Aged Obesity original-article Parameter sensitivity Physiological aspects Proteins Public Health Risk Sensitivity Serum Surveys and Questionnaires Testing Triglycerides Triglycerides - blood Iran
ISSN:	0954-3007, 1476-5640, 1476-5640
Online Access:	Get full text
Tags:	Add Tag No Tags, Be the first to tag this record!

Be the first to leave a comment!